EP4056590
BIOPHARMACEUTICAL COMPOSITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.8.2016EP published:
15.10.2025EP application number:
22152628.8
EPO information:
European Patent Register
Max expiry date:
21.8.2036
Title in English:
BIOPHARMACEUTICAL COMPOSITIONSLanguage of the patent:
English
Timeline
Today
22.8.2016EP application
15.10.2025EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property (No.2) LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
MONCK, Myrna, AAddress:
King of Prussia, 19406, US
Name:
BAM, Narendra, BAddress:
King of Prussia, 19406, US
Name:
DALLY, JenniferAddress:
King of Prussia, 19406, US
Name:
SPATARA, MichelleAddress:
King of Prussia, 19406, US
Priority
Number:
201562209000 PDate:
24.8.2015Country:
US
Number:
201562240131 PDate:
12.10.2015Country:
US
Number:
201562247906 PDate:
29.10.2015Country:
US
Number:
201562249497 PDate:
2.11.2015Country:
US
Classification
Categories:
C07K 16/24, C07K 1/16, A61P 9/00, A61P 1/04, A61P 37/08, A61P 17/02, A61P 11/06, A61P 11/02